ORIGINAL ARTICLE
Nuclear CK19-immunopositive pseudoinclusions as a new additional objective diagnostic feature of papillary thyroid carcinoma
More details
Hide details
1
Department of Pathology, Pomeranian Medical University, Szczecin, Poland
Publication date: 2020-05-20
Pol J Pathol 2020;71(1):1-6
KEYWORDS
ABSTRACT
One of the key parameters in the diagnosis of papillary thyroid carcinoma (PTC) are true nuclear pseudoinclusions (NPs), which constitute invaginations of the cytoplasm into the nucleus. On the other hand, strong cytoplasmic expression of CK19 is a well-known attribute of PTC tumor cells. We analyzed NPs using CK19 immunohistochemistry in histological sections of 52 PTCs and seven noninvasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTPs). Strong CK19+ NPs were present in 77% of PTCs, whereas NPs in hematoxylin and eosin (HE)-stained slides (HE NPs) were identified in only 48% of PTCs. Detection of CK19+ NPs enabled easier and objective recognition of NPs and better discrimination of NPs from pseudo-pseudoinclusions than detection of HE NPs. In the 15 of the 27 (55.5%) PTCs in which we could not discern HE NPs, strong CK19+ NPs could be identified reliably, quickly and easily. Moreover, all NIFTPs were negative for both CK19+ NPs and HE NPs. Detection of CK19+ NPs may refine the assessment of this important diagnostic feature and, hence, the microscopic diagnostic criteria of PTC. Thus, these findings may have implications for the accurate diagnosis of PTC and NIFTP.
REFERENCES (27)
1.
Rosai J, Albores Saavedra J, Asioli S, et al. Papillary thyroid carcinoma. In: Lloyd RV, Osamura RY, Klöppel G, Rosai J. WHO classification of tumours of endocrine organs. IARC Lyon, 2017; pp. 81-91.
2.
Ip YT, Dias Filho MA, Chan JK. Nuclear inclusions and pseudoinclusions: friends or foes of the surgical pathologist? Int J Surg Pathol 2010; 18:465-481.
3.
Yang SW, Yang KM, Kang H, et al. Intranuclear cytoplasmic pseudoinclusions in pituitary adenomas. Yonsei Med J 2003; 44: 816-820.
4.
Kini SR, Miller JM, Hamburger JI, et al. Cytopathology of papillary carcinoma of the thyroid by fine needle aspiration. Acta Cytol 1980; 24: 511-521.
5.
Miller TR, Bottles K, Holly EA, et al. A step-wise logistic regression analysis of papillary carcinoma of the thyroid. Acta Cytol 1986; 30: 285-293.
6.
Bizzarro T, Martini M, Capodimonti S, et al. Young investigator challenge: The morphologic analysis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on liquid-based cytology: Some insights into their identification. Cancer Cytopathol 2016; 124: 699-710.
7.
Scharpf J, Kamani D, Sadow PM, et al. The follicular variant of papillary thyroid cancer and noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). Curr Opin Oncol 2017; 29: 20-24.
8.
LiVolsi VA. Papillary thyroid carcinoma: an update. Mod Pathol 2011; 24 Suppl 2: S1-S9.
9.
Cracolici V, Krausz T, Cipriani NA. Ubiquitin Immunostaining in Thyroid Neoplasms Marks True Intranuclear Cytoplasmic Pseudoinclusions and May Help Differentiate Papillary Carcinoma from NIFTP. Head Neck Pathol 2018; 12: 522-528.
10.
Flanagan JN, Pineda P, Knapp PE, et al. Expression of cytokeratin 19 in the diagnosis of thyroid papillary carcinoma by quantitative polymerase chain reaction. Endocr Pract 2008; 14: 168-174.
11.
Cheung CC, Ezzat S, Freeman JL, et al. Immunohistochemical diagnosis of papillary thyroid carcinoma. Mod Pathol 2001; 14: 338-342.
12.
Raphael SJ, McKeown-Eyssen G, Asa SL. High-molecular-weight cytokeratin and cytokeratin-19 in the diagnosis of thyroid tumors. Mod Pathol 1994; 7: 295-300.
13.
Sahoo S, Hoda SA, Rosai J, et al. Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma: a note of caution. Am J Clin Pathol 2001; 116: 696-702.
14.
Cameron BR, Berean KW. Cytokeratin subtypes in thyroid tumours: immunohistochemical study with emphasis on the follicular variant of papillary carcinoma. J Otolaryngol 2003; 32: 319-322.
15.
Erkilic S, Kocer NE. The role of cytokeratin 19 in the differential diagnosis of true papillary carcinoma of thyroid and papillary carcinoma-like changes in Graves’ disease. Endocr Pathol 2005; 16: 63-66.
16.
Scognamiglio T, Hyjek E, Kao J, et al. Diagnostic usefulness of HBME1, galectin-3, CK19, and CITED1 and evaluation of their expression in encapsulated lesions with questionable features of papillary thyroid carcinoma. Am J Clin Pathol 2006; 126: 700-708.
17.
Nikiforov YE, Ghossein RA, Kakudo K, et al. Non-invasive follicular thyroid neoplasm with papillary-like nuclear features. In: Lloyd RV, Osamura RY, Klöppel G, Rosai J. WHO classification of tumours of endocrine organs. IARC Lyon, 2017; pp. 78-80.
18.
Handra-Luca A, Tissier F. Nucleolar Cytokeratin 19 in Thyroid Carcinoma. Appl Immunohistochem Mol Morphol 2017; 25: e37.
19.
Fricker M, Hollinshead M, White N, et al. Interphase nuclei of many mammalian cell types contain deep, dynamic, tubular membrane-bound invaginations of the nuclear envelope. J Cell Biol 1997; 136: 531-544.
20.
Asioli S, Bussolati G. Emerin immunohistochemistry reveals diagnostic features of nuclear membrane arrangement in thyroid lesions. Histopathology 2009; 54: 571-579.
21.
Solomon A, Gupta PK, LiVolsi VA, et al. Distinguishing tall cell variant of papillary thyroid carcinoma from usual variant of papillary thyroid carcinoma in cytologic specimens. Diagn Cytopathol 2002; 27: 143-148.
22.
Rossi S, Fugazzola L, De Pasquale L, et al. Medullary and papillary carcinoma of the thyroid gland occurring as a collision tumour: report of three cases with molecular analysis and review of the literature. Endocr Relat Cancer 2005; 12: 281-289.
23.
Scopa CD, Melachrinou M, Saradopoulou C, et al. The significance of the grooved nucleus in thyroid lesions. Mod Pathol 1993; 6: 691-694.
24.
Casey MB, Sebo TJ, Carney JA. Hyalinizing trabecular adenoma of the thyroid gland: cytologic features in 29 cases. Am J Surg Pathol 2004; 28: 859-867.
25.
Howitt BE, Chang S, Eszlinger M, et al. Fine-needle aspiration diagnoses of noninvasive follicular variant of papillary thyroid carcinoma. Am J Clin Pathol 2015; 144: 850-857.
26.
Seethala RR, Baloch ZW, Barletta JA, et al. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a review for pathologists. Mod Pathol 2018; 31: 39-55.
27.
Johnson DN, Furtado LV, Long BC, et al. Noninvasive Follicular Thyroid Neoplasms With Papillary-like Nuclear Features Are Genetically and Biologically Similar to Adenomatous Nodules and Distinct From Papillary Thyroid Carcinomas With Extensive Follicular Growth. Arch Pathol Lab Med 2018; 142: 838-850.